Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
109 studies found for:    "factor V Leiden thrombophilia" OR "Thrombophilia"
Show Display Options
Rank Status Study
21 Completed Hypercoagulability After Breast Cancer Surgery
Conditions: Breast Cancer;   Blood Coagulation Disorders
Intervention: Procedure: Blood collection (pre and postoperative): plasma coagulation parameters
22 Unknown  ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery
Conditions: Graft Patency;   Coronary Artery Bypass Grafting Surgery;   Hypercoagulability;   Thrombosis
Interventions: Drug: Clopidogrel+acetylsalicylic acid;   Drug: acetylsalicylic acid
23 Completed Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?
Condition: Chest Pain
Intervention:
24 Completed Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1-
Condition: Myeloproliferative Neoplasm
Intervention: Other: Blood sampling
25 Recruiting Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention:
26 Unknown  Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
Conditions: Non-Small Cell Lung Carcinoma;   Venous Thromboembolism
Intervention: Procedure: Blood sample withdrawal
27 Completed Guilford Genomic Medicine Initiative (GGMI)
Conditions: Breast Cancer;   Ovarian Cancer;   Colon Cancer;   Thrombophilia
Intervention:
28 Completed Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)
Condition: Venous Thrombosis
Intervention: Other: Blood sample
29 Not yet recruiting Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response
Conditions: Ovarian Hyperstimulation Syndrome;   Hypercoagulability
Intervention: Other: COAGO
30 Unknown  Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Conditions: Antiphospholipid Syndrome;   Thrombophilia Due to Antiphospholipid Antibody;   Systemic Lupus Erythematosus
Intervention: Other: Phlebotomy
31 Terminated Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
Conditions: Venous Thromboembolism;   Fetal Death
Intervention: Other: Thrombophilia Testing
32 Enrolling by invitation Pulmonary Embolism After Liver Resection
Conditions: Liver Disease;   Pulmonary Embolism;   Thrombophilia;   Death
Interventions: Procedure: Liver resection;   Radiation: Computed Tomography
33 Completed Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies
Conditions: Pregnancy;   Iron Deficiency;   Iron Deficiency Anemia
Interventions: Dietary Supplement: Lattoglobina (Grunenthal) containing bLf;   Drug: FerroGrad by Abbott
34 Completed Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
Conditions: Recurrent Pregnancy Loss;   Fetal Demise;   Abortion, Habitual;   Antiphospholipid Antibodies;   Inherited Thrombophilia
Intervention:
35 Completed Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial
Condition: Deep Venous Thrombosis
Intervention:
36 Completed Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: DLBS1033;   Drug: placebo tablet of DLBS1033
37 Completed Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome
Conditions: Venous Thrombosis;   Venous Insufficiency
Intervention:
38 Completed Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test
Conditions: Factor V Leiden;   Factor II;   Thrombosis
Intervention:
39 Active, not recruiting Low Weight Heparin prOphylaxis for Placental‐Mediated Complications of PrEgnancy
Conditions: High Risk Pregnant Women;   Placental Insufficiency;   Preeclampsia
Intervention: Drug: Enoxaparin
40 Unknown  The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin
Conditions: Acute Coronary Syndrome;   Venous Thromboembolism;   Atrial Fibrillation;   Hypercoagulability
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.